Neurocrine Clinical Site

Richmond, Texas 77407

0 studies enrolling now · 3 studies all time

What they study most

Major Depressive Disorder, Tardive Dyskinesia (TD)

Studies at this site

• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia — Completed